Paclitaxel enhances IRE1 RNase activity that leads to the production of IL6, IL8, CXCL1, GM-CSF, and TGFβ2 in breast cancer cells contributing to the expansion of tumor-initiating cells (153). Here, IL6 is linked to breast cancer.